PEN Penumbra, Inc.

NYSE
$322.17

Penumbra, Inc. (PEN) is expected to report earnings on November 3, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -0.3% since its last earnings release on July 30, 2026.

Penumbra Missed Consensus Estimates
Thursday, July 30, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs -
Rev est $1.6B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $323.88

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Penumbra, Inc.

Penumbra, Inc. is a global healthcare company focused on innovative therapies.

Sector

Healthcare

Industry

Medical Appliances/Equipment